Clinical Trials Directory

Trials / Completed

CompletedNCT03395262

An Examination of a Weight Loss Formula on Health

An Examination of a Novel Weight Loss Formula on Anthropometry and Indices of Cardiovascular Disease Risk

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
80 (actual)
Sponsor
Texas A&M University · Academic / Other
Sex
All
Age
30 Years – 45 Years
Healthy volunteers
Accepted

Summary

The aim of this study is to examine a novel weight loss formula with and without common stimulants on anthropometry and indices of cardiovascular disease risk.

Detailed description

Obesity remains a problem for overall health and risk for cardiovascular disease worldwide. While dietary modification and increased levels of physical activity remain steadfast recommendations, alternative strategies related to supplementation remain an interest for the general populace and medical communities. A potential objection to the use of dietary supplements is that they often contain stimulants designed to increase metabolism. However, consumers and health practitioners alike are wary of such formulae; hence, the continued investigation of non-stimulant supplements is warranted. Therefore the aim of this study is to examine a novel weight loss formula with and without common stimulants on anthropometry and indices of cardiovascular disease risk.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTActive with caffeineNovel formula with caffeine
DIETARY_SUPPLEMENTActive without caffeineNovel formula without caffeine
DIETARY_SUPPLEMENTPlaceboDextrose placebo

Timeline

Start date
2017-06-01
Primary completion
2018-03-31
Completion
2018-12-31
First posted
2018-01-10
Last updated
2019-09-10

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03395262. Inclusion in this directory is not an endorsement.